Back to News
Market Impact: 0.2
Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development
Source: PR Newswire
Management & GovernanceHealthcare & BiotechCompany Fundamentals
Everest Medicines appointed Lakshmi Srinivasan, PhD, former Moderna Executive Director and Head of Oncology Translational Medicine, and Brandon Coder, PhD, former Research & Early Translational Lead for Cancer Vaccines at Moderna. The appointments are intended to support continued advancement of Everest’s mRNA programs; no financial figures or market reaction are provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
MRNA0.00
More News
- Moderna options activity surges as Nasdaq-100 inclusion and melanoma data drive call buying
- For the final 10% of cystic fibrosis, the breakthrough still hasn't come
- Why Moderna Stock Surged Today
- Wall Street Week | Michigan Manufacturing, AI Debt Investments, Baby Bonds, Canadian Coal Fight
- Tesla drops 'Full Self-Driving' brand name in Europe after regulator pushback
- ‘I drive a Tesla’: After Elon Musk said he’d lose his job, Delta CEO Ed Bastian says there’s ‘no tit for tat’ as airline unveils earnings miss